Lactic acidosis due to metformin;Acidosis láctica por metformina

Medicina Interna de Mexico

Volumn 26, Issue 3, 2010, Pages 276-280

  Carrillo Esper, Raúl ^a,b   Sosa García, Jesús Ojino ^c  

^a Academia Mexicana de Cirugia AC   (Mexico)

^b LIVER RESEARCH UNIT   (Mexico)

^c Medicina del Enfermo en Estado Crítico ^*

Author keywords

Lactic acidosis; Metformin; Renal failure

Indexed keywords

LACTIC ACID; METFORMIN;

AGED; ALERTNESS; ANEMIA; ARTICLE; CASE REPORT; DEHYDRATION; DIARRHEA; HEMODIALYSIS; HUMAN; HYPERKALEMIA; KIDNEY FAILURE; LACTIC ACIDOSIS; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OLIGURIA; RESPIRATORY DISTRESS; RISK FACTOR; SEPSIS;

EID: 77953567997     PISSN: 01864866     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Federación Mexicana de Diabetes. Estadísticas en Salud. http://www.fmdiabetes.org 15 de abril 2009.
2. American Diabetes Association. Total prevalence of diabetes and pre-diabetes. Available at: http://www.diabetes.org/diabetes-statistics/ prevalence.jsp. Accessed October 5, 2006.
3. Nathan DM, Buse JB, Davidson MB. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2006;29:1963-1972.
4. UK Prospective Diabetes Study (UKPDS) group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865. (Pubitemid 28416719)
5. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care 1989;12:553-564. (Pubitemid 19214828)
6. Sterne J. Pharmacology and mode of action of hypoglycaemic guanidine derivatives. In: Campbell GD, editor. Oral hypoglycaemic agents. London: Academic, 1969;pp:193-245.
7. Beckmann R. Biguanide (Experimenteller Teil). In: Maske H, editor. Oral wirksame Antidiabetika. Vol. 29 of Handbuch der experimentellen Pharmakologie. Berlin, Germany: Springer-Verlag, 1971;pp:439-596.
8. Nattrass M, Alberti KGMM. Biguanides. Diabetologia 1978;14:71-74.
9. Peters N, Jay N, Barraud D, et al. Metformin-associated lactic acidosis in an intensive care unit. Critical Care 2005;12;6:1-5.
10. Jones G, Macklin J, Alexander W. Contraindications to the use of metformin. BMJ 2003;326:4-5.
11. Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 1996;30:359-371.
12. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;29:574-579.
13. Misbin RI, Green L, Stadel BV, et al. Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 1998;338:265-266. (Pubitemid 28047587)
14. Salpeter S, Greyber E, Pasternak G. Risk of fatal and non fatal lactic acidosis with metformin in type 2 diabetes mellitus. Cochrane Database Syst Rev 2006; CD002967.
15. Jones GC, Macklin JP, Alexander WD. Contraindications to the use of metformin. BMJ 2003;3265:4-5.
16. Stades AM, Heikens JT, Erkelens DW. Metformin and lactic acidosis: Cause or coincidence? A review of case reports. J Intern Med 2004;255:179-187.
17. Spiller HA, Weber JA, Winter ML. Multicenter case series of pediatric metformin ingestion. Ann Pharmacother 2000;34:1385-1388.
18. Brown JB, Pedula MS, Barzilay J, et al. Lactic acidosis rates in type 2 diabetes. Diabetes Care 1998;21:1659 1663.
19. Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996;81:4059-4067. (Pubitemid 26380418)
20. Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000;348:607-614. (Pubitemid 30410251)
21. El-Mir MY, Nogueira V, Fontaine E, et al. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 2000;275:223-228. (Pubitemid 30038975)
22. Lebacq EG, Tirzmalis A. Metformin and lactic acidosis. Lancet 1972;1:314-315.
23. Stades A, Heinkens J, Erkenlens D, et al. Metformin and lactic acidosis: cause or coincidence? A review of case report. J Int Med 2004;255:179-187. (Pubitemid 38241362)
24. Guo PY, Storsley LJ, Finkle SN. Severe lactic acidosis treated with prolonged hemodialysis: Recovery after massive overdoses of metformin. Semin Dial 2006;19:80-83.
25. Robert F, Fendri S, Hary L. Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects. Diabetes Metab 2003;29:279-283. (Pubitemid 36807438)
26. Lalau JD, Lacroix C. Measurement of metformin concentration in erythrocytes: Clinical implications. Diabetes Obes Metab 2003;5:93-98. (Pubitemid 36372500)
27. Barrueto F, Meggs WJ, Barchman MJ. Clearance of metformin by hemofiltration in overdose. J Toxicol Clin Toxicol 2002;40:177-180.
28. Panzer U, Kluge S, Kreymann G, Wolf G. Combination of intermittent haemodialysis and the high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis. Nephrol Dial Transplant 2004;19:2157-2158. (Pubitemid 39139660)
29. Silvestre J, Carvalho S, Mendes V, et al. Metformin-induced lactic acidosis: a case series. Journal of Medical Case Reports 2007;1:126.
30. Lalau JD, Race JM. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 1999;20:377-384.
31. Seidowsky A, Nseir S, Houdret N, et al. Metformin-associated lactic acidosis: A prognostic and therapeutic study. Crit Care Med 2009;37:2191-2196.